The short version
6 companies supply this market — a reasonable cushion if one runs into trouble. The price has jumped 121% in a year, to $0.3288 per mL — sharp rises like this often mean supply is already tightening. It is in shortage right now — FDA lists the reason as “demand increase for the drug”. One of its named manufacturing plants, International Medication Systems, Ltd., failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: worth watching — several of the pressures that precede supply trouble are present at once.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.